Gene Techno Science Co., Ltd. is a biomedicine company that researches and developes drugs. In addition to drug development, the company also supply the pharmaceutical ingredients.

Summary Of Consolidated Financial Results For 2q Of The Fiscal Year Ended March 31, 2026

Financial Results For Fy2025 Q2

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Gene Techno Science (4584 JP)

Summary Of Consolidated Financial Results For 2q Of The Fiscal Year Ended March 31, 2026

Financial Results For Fy2025 Q2

Agreement In Principle To Establish A Joint Venture Alliance For The Development Of Domestic Manufacturing Facility For Biosimilars

Execution Of Agreements Regarding The Joint Development Of Biosimilars For Specified Products

Summary Of Consolidated Financial Results For The Fiscal Year Ended March 31, 2026

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)